✦ LIBER ✦

Bisphosphonates as adjuvant therapy for breast cancer

✍ Scribed by Michael Gnant; Peter Dubsky; Florian Fitzal; Thomas Bachleitner-Hofmann; Ruth Exner; Peter Blaha; Raimund Jakesz; Walter Schippinger; Richard Greil

Book ID: 107671244
Publisher: Springer-Verlag
Year: 2009
Tongue: English
Weight: 435 KB
Volume: 1
Category: Article
ISSN: 1943-4588
DOI: 10.1007/s12609-009-0008-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of bisphosphonates as adjuvant

The role of bisphosphonates as adjuvant therapy for breast cancer

✍ Julie R. Gralow 📂 Article 📅 2001 🏛 Current Science Inc. 🌐 English ⚖ 405 KB

Adjuvant therapy for breast cancer

✍ S. Rodenhuis; E. J. T. Rutgers 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views

Requires sophistication

Breast cancer adjuvant therapy

✍ Paul P. Carbone 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 755 KB

Combined modality trials in early breast cancer have been underway since the 1960s and results are available to indicate varying degrees of success in Stage I and 11. The trials have involved more than 29,000 women in 61 randomized trials. The recommendations can be summarized by stage, estrogen rec

Prevention of bone metastases from breas

Prevention of bone metastases from breast cancer by adjuvant bisphosphonate therapy

✍ Norio Kohno; Ikuo Kokufu 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 426 KB

Surgical adjuvant therapy for breast can

Surgical adjuvant therapy for breast cancer

✍ Bernard Fisher 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 834 KB

Adjuvant therapy of breast cancer

✍ Nancy E. Davidson; Martin D. Abeloff 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 605 KB

About 180,000 American women will be diagnosed with early stage breast cancer during 1993. In many of these patients breast cancer is a systemic disease at diagnosis and thus not curable by local treatment alone. The development of optimal forms of systemic adjuvant therapy has been a major area of